LESSONS LEARNED FROM ALTERNATIVE METHODS AND THEIR VALIDATION FOR A NEW TOXICOLOGY IN THE 21ST CENTURY

被引:50
作者
Hartung, Thomas [1 ,2 ]
机构
[1] Johns Hopkins Univ, Ctr Alternat Anim Testing, Bloomberg Sch Publ Hlth, Baltimore, MD USA
[2] Univ Konstanz, Dept Pharmacol & Toxicol, Constance, Germany
来源
JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART B-CRITICAL REVIEWS | 2010年 / 13卷 / 2-4期
关键词
EMBRYONIC STEM-CELLS; IN-VITRO; PHARMACOKINETIC MODELS; FOOD; THOUGHT; DRUG; UNCERTAINTY; ASSESSMENTS; EVOLUTION; CHEMICALS;
D O I
10.1080/10937404.2010.483945
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Europe and the United States further the development of new toxicological tools in different ways. While the replacement of animal tests has been promoted strongly in Europe over the last decades (following the 3Rs principles-reduce, replace, refine), in the United States the vision for a toxicology in the 21st century (Tox-21c), which was prompted by the National Research Council document only 3 years ago, dominates the discussion. In both cases, there is significant political support. However, while in Europe the horizontal animal welfare legislation from 1986 (which urges the use of 3Rs methods wherever possible) currently under revision and cosmetics and chemical legislation are the primary drivers, in the United States it is mainly federal agencies, most prominently the U. S. Environmental Protection Agency (EPA), that made the implementation of the NRC report their toxicity testing strategy only in 2009. This preempts such likely legislative measures as the reauthorization of the Toxic Substances Control Act (TSCA) in the United States. The European implementation is characterized by substantial broad funding programs to develop 3Rs methods and can be termed a "bottom-up" approach; in contrast, the Tox-21 program represents a "top-down" approach, where programmed research is carried out and commissioned. It is postulated that the two approaches are two sides of the same coin, and instruct and complement each other. However, more importantly, if brought together they can result in a Human Toxicology Project and a real revolution in regulatory toxicology.
引用
收藏
页码:277 / 290
页数:14
相关论文
共 63 条
[11]   The development of new concepts for assessing reproductive toxicity applicable to large scale toxicological programmes [J].
Bremer, S. ;
Pellizzer, C. ;
Hoffmann, S. ;
Seidle, T. ;
Hartung, T. .
CURRENT PHARMACEUTICAL DESIGN, 2007, 13 (29) :3047-3058
[12]   The use of embryonic stem cells for regulatory developmental toxicity testing in vitro -: The current status of test development [J].
Bremer, S ;
Hartung, T .
CURRENT PHARMACEUTICAL DESIGN, 2004, 10 (22) :2733-2747
[13]   Evaluation of physiologically based pharmacokinetic models for use in risk assessment [J].
Chiu, Weihsueh A. ;
Barton, Hugh A. ;
DeWoskin, Robert S. ;
Schlosser, Paul ;
Thompson, Chad M. ;
Sonawane, Babasaheb ;
Lipscomb, John C. ;
Krishnan, Kannan .
JOURNAL OF APPLIED TOXICOLOGY, 2007, 27 (03) :218-237
[14]   Development and specification of physiologically based pharmacokinetic models for use in risk assessment [J].
Clewell, Rebecca A. ;
Clewell, Harvey J., III .
REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2008, 50 (01) :129-143
[15]   Guidance on Good Cell Culture Practice - A report of the second ECVAM task force on Good Cell Culture Practice [J].
Coecke, S ;
Balls, M ;
Bowe, G ;
Davis, J ;
Gstraunthaler, G ;
Hartung, T ;
Hay, R ;
Merten, OW ;
Price, A ;
Schechtman, L ;
Stacey, G ;
Stokes, W .
ATLA-ALTERNATIVES TO LABORATORY ANIMALS, 2005, 33 (03) :261-287
[16]   Workgroup report:: Incorporating in vitro alternative methods for developmental neurotoxicity into international hazard and risk assessment strategies [J].
Coecke, Sandra ;
Goldberg, Alan M. ;
Allen, Sandra ;
Buzanska, Leonora ;
Calamandrei, Gemma ;
Crofton, Kevin ;
Hareng, Lars ;
Hartung, Thomas ;
Knaut, Holger ;
Honegger, Paul ;
Jacobs, Miriam ;
Lein, Pamela ;
Li, Abby ;
Mundy, William ;
Owen, David ;
Schneider, Steffen ;
Silbergeld, Ellen ;
Reum, Torsten ;
Trnovec, Tomas ;
Monnet-Tschudi, Florianne ;
Bal-Price, Anna .
ENVIRONMENTAL HEALTH PERSPECTIVES, 2007, 115 (06) :924-931
[17]   Toxicology - Transforming environmental health protection [J].
Collins, Francis S. ;
Gray, George M. ;
Bucher, John R. .
SCIENCE, 2008, 319 (5865) :906-907
[18]   Early microdose drug studies in human volunteers can minimise animal testing: Proceedings of a workshop organised by Volunteers in Research and Testing [J].
Combes, RD ;
Berridge, T ;
Connelly, J ;
Eve, MD ;
Garner, RC ;
Toon, S ;
Wilcox, P .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2003, 19 (01) :1-11
[19]   Meeting report: Validation of toxicogenomics-based test systems: ECVAM-ICCVAM/NICEATM considerations for regulatory use [J].
Corvi, R ;
Ahr, HJ ;
Albertini, S ;
Blakey, DH ;
Clerici, L ;
Coecke, S ;
Douglas, GR ;
Gribaldo, L ;
Groten, JP ;
Haase, B ;
Hamernik, K ;
Hartung, T ;
Inoue, T ;
Indans, I ;
Maurici, D ;
Orphanides, G ;
Rembges, D ;
Sansone, SA ;
Snape, JR ;
Toda, E ;
Tong, WD ;
van Delft, JH ;
Weis, B ;
Schechtman, LM .
ENVIRONMENTAL HEALTH PERSPECTIVES, 2006, 114 (03) :420-429
[20]  
Devolder T, 2008, ALTEX-ALTERN TIEREXP, V25, P233